About
21.22USD-0.32 -1.49%
Closed • Updated at 02:14 GMT+00:00Market Cap$744.69M
Volume271.4K
Beta1.80
RSI39.89
Alto Neuroscience, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 15 2026
Alto Neuroscience CEO Amit Etkin, M.D., Ph.D. Receives Columbia University Transformational Research Award
May 13 2026
Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 4 2026
Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting
Apr 21 2026
Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression
Apr 1 2026
Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements
Community Chat
Ask AI
Try asking
Translate